These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Perampanel in 12 patients with Unverricht-Lundborg disease. Crespel A; Gelisse P; Tang NP; Genton P Epilepsia; 2017 Apr; 58(4):543-547. PubMed ID: 28166365 [TBL] [Abstract][Full Text] [Related]
5. Seizure control in Unverricht-Lundborg disease: a single-centre study. Roivainen R; Karvonen MK; Puumala T Epileptic Disord; 2014 Jun; 16(2):191-5. PubMed ID: 24777117 [TBL] [Abstract][Full Text] [Related]
6. First Molecular Diagnosis of a Patient with Unverricht-Lundborg Disease in Korea. Kim KH; Song JS; Park CW; Ki CS; Heo K Yonsei Med J; 2018 Aug; 59(6):798-800. PubMed ID: 29978618 [TBL] [Abstract][Full Text] [Related]
7. Antiepileptic drug intervention decouples electroencephalogram (EEG) signals: a case study in Unverricht-Lundborg Disease. Liu CC; Xanthopoulos P; Chaovalitwongse W; Pardalos PM; Uthman BM Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():2108-11. PubMed ID: 19163112 [TBL] [Abstract][Full Text] [Related]
9. A clinical and neurophysiological motor signature of Unverricht-Lundborg disease. Hainque E; Blancher A; Mesnage V; Rivaud-Pechoux S; Bertrand A; Dupont S; Navarro V; Roze E; Gourfinkel-An I; Apartis E Rev Neurol (Paris); 2018; 174(1-2):56-65. PubMed ID: 28688606 [TBL] [Abstract][Full Text] [Related]
10. Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations. Magaudda A; Gelisse P; Genton P Epilepsia; 2004 Jun; 45(6):678-81. PubMed ID: 15144434 [TBL] [Abstract][Full Text] [Related]
11. Brivaracetam in Unverricht-Lundborg disease (EPM1): Results from two randomized, double-blind, placebo-controlled studies. Kälviäinen R; Genton P; Andermann E; Andermann F; Magaudda A; Frucht SJ; Schlit AF; Gerard D; de la Loge C; von Rosenstiel P Epilepsia; 2016 Feb; 57(2):210-21. PubMed ID: 26666500 [TBL] [Abstract][Full Text] [Related]
12. Long-term evolution of EEG in Unverricht-Lundborg disease. Gargouri-Berrechid A; Nasri A; Kacem I; Sidhom Y; Abdelkefi I; Hizem Y; Ben Djebrara M; Gouider R Neurophysiol Clin; 2016 Apr; 46(2):119-24. PubMed ID: 27157382 [TBL] [Abstract][Full Text] [Related]
13. [Low-dose perampanel improved cortical myoclonus and basophobia in a patient with Unverricht-Lundborg disease: a case report]. Oi Y; Kobayashi K; Hitomi T; Matsumoto R; Ikeda A; Takahashi R Rinsho Shinkeigaku; 2018 Oct; 58(10):622-625. PubMed ID: 30270337 [TBL] [Abstract][Full Text] [Related]
14. A pilot open-label trial of zonisamide in Unverricht-Lundborg disease. Italiano D; Pezzella M; Coppola A; Magaudda A; Ferlazzo E; Bramanti P; Striano S; Zara F; Striano P Mov Disord; 2011 Feb; 26(2):341-3. PubMed ID: 20939070 [TBL] [Abstract][Full Text] [Related]
15. T2-weighted high-intensity signals in the basal ganglia as an interesting image finding in Unverricht-Lundborg disease. Korja M; Ferlazzo E; Soilu-Hänninen M; Magaudda A; Marttila R; Genton P; Parkkola R Epilepsy Res; 2010 Jan; 88(1):87-91. PubMed ID: 19896804 [TBL] [Abstract][Full Text] [Related]
16. [Unverricht-Lundborg disease manifesting tremulous myoclonus with rare convulsive seizures: a case report]. Kondo T; Yamakado H; Kawamata J; Tomimoto H; Hitomi T; Takahashi R; Ikeda A Rinsho Shinkeigaku; 2009 Jan; 49(1):43-7. PubMed ID: 19227896 [TBL] [Abstract][Full Text] [Related]